Chemkart India Ltd — Important, 11-09-2025: Company Update

Chemkart India released its Investor Presentation, detailing its operations as a B2B supplier of raw ingredients for nutritional and health supplements. A key strategic focus is the upcoming greenfield CDMO facility at its wholly-owned subsidiary EZRM in JNPT SEZ, Maharashtra. This facility, projected to be operational by FY27, will target global markets for health supplements, leveraging novel ingredient technologies for manufacturing and exports. Financially, for FY25, the company reported revenue of 203.28 Cr, EBITDA of 32.76 Cr (16.1% margin), and PAT of 24.26 Cr (11.9% margin), with ROE at 45.43% and ROCE at 48.94%. India's nutraceutical market is projected to reach USD 76 billion by 2033, showing significant growth potential.